| Financial Year |
March 31 2023 |
| Monetary Funds |
6,004,619,452.37 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
699,767,988.12 |
| Accounts Receivable |
5,828,014,179.27 |
| Advances to Suppliers |
128,108,902.55 |
| Other Receivables |
37,965,723.50 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
8,112,498.57 |
| Dividend Receivable |
-- |
| Inventories |
1,840,921,097.07 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
104,903,459.42 |
| Total Current Assets |
16,148,398,565.04 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,253,236,596.89 |
| Investment Properties |
4,111,479.61 |
| Fixed Assetes |
1,556,388,324.52 |
| Under-construction Projects |
488,758,943.17 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
676,592,816.97 |
| R&D expenses |
214,290,197.12 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
24,175,470.29 |
| Deferred Income Tax Assets |
218,011,300.06 |
| Other Non-Current Assets |
15,505,727.99 |
| Sub-Total of Non-Current Assets |
5,447,594,319.83 |
| Total Assets |
21,595,992,884.87 |
| Short-Term Loans |
1,019,486,250.65 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,706,686,476.30 |
| Accounts Payable |
3,847,327,357.24 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
197,553,142.53 |
| Taxes Payable |
24,886,569.67 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
513,418,027.26 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
653,630,128.86 |
| Other Current Liabilities |
2,002,988,173.91 |
| Sub-Total of Current Liabilities |
11,396,667,762.81 |
| Long-term Loans |
2,437,700,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,717,511,831.49 |
| Total Liabilities |
14,114,179,594.30 |
| Paid-In Capital(Or Share Stock) |
1,631,535,732.00 |
| Capital Surplus |
6,505,011,103.14 |
| Surplus Reserve |
640,078,219.47 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-1,331,989,137.66 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
7,481,813,290.57 |
| Owner's Equity（Stockholder's Equity） |
7,481,813,290.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
21,595,992,884.87 |
